U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

Recruiting now · Not applicable

Conditions studied: Bone Tumor, Osteoporosis, Traumatic Fracture

In brief

The goal of this investigational device exemption is to evaluate the Epione assistance for introducer placement during percutaneous procedures in musculo-skeletic (MSK) structures of the pelvis and the spine in adults. The main question is the determination of the rate of feasible procedures assisted by the Epione device Participants will undergo their procedure(s) as planned by their physician. If they accept to participate to the study, the differences with standard of care will be: * The use of the Epione device to place the introducer(s), instead of freehand placement if they do not participate * Additional CT or CBCT scans during the procedure.

Key facts

Study ID

NCT07325578

Run by

Precision IO Group

People needed

60

Starts

2026-04-28

Expected to finish

2027-03-01

Last updated by the study team

2026-07-20

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ≥22 years old,
• Patients approved for CT- or CBCT-guided MSK procedure in the pelvis or spine (except the cervical area) under general anesthesia,
• Patients who have signed an IRB-approved informed consent form
• Patients approved for coverage by their insurance for routine costs involved in this standard of care procedure
• Inclusion criteria linked to the freehand procedure have been discussed and validated

You may not qualify if…

• Patients with contraindication to undergo general anesthesia,
• Patients unable to maintain appropriate breathing control,
• Patients requiring CT- or CBCT-guided percutaneous procedure on target areas other than those indicated
• Patients unable to fully understand all relevant aspects of the clinical study necessary for their decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response,
• Pregnant or breast-feeding women,
• Patients subject to a legal protection measure,
• Patients already participating in another conflicting interventional clinical study,
• Patients for whom the scan field of view cannot contain the anatomy of interest, the overlaying skin surface, skin markers and the whole patient reference.
• Patients having a coagulation abnormalities or bleeding disorder
• Patients having an active infection on the day of intervention
• Patients having a history of previous surgery resulting in an existing hardware precluding percutaneous approach
• Exclusion criteria linked to the freehand procedure have been discussed and validated

Where it is running

• UC San Diego — San Diego, California, United States (enrolling)
• Baptist Hospital Of Miami, Inc — Miami, Florida, United States (enrolling)
• Rush University Medical Center — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.